Transplantation Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Case series of multiple myeloma and kidney transplant outcome: Clinical characteristics and long-term follow-up 2024
• Report of the Standardized Outcomes in Nephrology-transplant Consensus Workshop on Establishing a Core Outcome Measure for Infection in Kidney Transplant Recipients 2024
• Re-evaluating the 6 month rule prior to liver transplant: a clinical practice guideline 2023
• A Data-driven Predictive Analytics Framework for the Analysis of Prognostic Factors and Health Outcomes in Paediatric Intestinal Failure Patients 2022
• AP39 Administration During Normothermic Ex Vivo Kidney Perfusion Reduces Preservation Injury 2022
• P.169: Canada-DONATE: Preliminary results from a mutlicentre prospective observational study. 2019
• DONATE 2017
• Development of Canadian National Guidelines for Pediatric Donation After Circulatory Determined Death (pDCD) 2017
• Radiofrequency Ablation as the First Treatment Option for HCC in Transplantable Patients. Is this the Best Strategy? 2017
• Living kidney donor priorities for outcomes: a nominal group technique study 2016
• Primary or Secondary Malignant Liver Tumors: A New Application of Old Serum Biomarkers 2016
• Class II HLA Eplet Load Is a Risk Factor for Transplant Glomerulopathy. 2014
• Gout in Living Kidney Donors. 2014
• Immune Sensitization and Mortality On the Waiting List for Kidney Transplantation. 2014
• Incidence of Post-Transplant Hyperglycemia and New-Onset Diabetes After Transplantation (NODAT) in Pediatric Solid Organ Transplant (SOT) Recipients. 2014
• Inhibition of Lymphocyte Activation in Response to HLA Derived Peptides in Renal Transplant Recipients. 2014
• Racial Variation in the Use of Antihypertensive Medications After Living Kidney Donation. 2014
• Secular Trends in Cardiovascular Disease Among Kidney Transplant Recipients. 2014
• Gout in Living Kidney Donors. 2014
• Racial Variation in the Use of Antihypertensive Medications After Living Kidney Donation. 2014
• Secular Trends in Cardiovascular Disease Among Kidney Transplant Recipients. 2014
• Estimating differential renal function using ellipsoid approximation of renal volume on CT scan 2013
• Estimating differential renal function using ellipsoid approximation of renal volume on CT scan 2013
• Adolescent Classroom Education on Knowledge and Attitudes About Deceased Organ Donation: A Systematic Review 2012
• The Beanstalk Program: Developmentally Focused Care for the Young Transplant Child During Prolonged Hospitalization 2012
• Living Kidney Donors Requiring Transplantation: Focus on African Americans 2007
• HLA allele level matching using DNA methods and its impact on graft outcome of cadaver kidney transplant with zero HLA-antigen mismatch shared according to UNOS policy. 2000
• DIFFERENTIAL EFFECTS OF DENDRITIC CELLS OVEREXPRESSING MAMMALIAN IL-10 ON ORGAN ALLOGRAFT AND ANTI-TUMOR IMMUNITY 1999
• The Impact of Liver Transplantation on Health-Related Quality of Life 1999
• Ethical Issues in Normothermic Regional Perfusion in Controlled Organ Donation After Determination of Death by Circulatory Criteria: A Scoping Review..  109:597-609. 2025
• Advancing the Scientific Basis for Determining Death in Controlled Organ Donation After Circulatory Determination of Death.  108:2197-2208. 2024
• Case series of multiple myeloma and kidney transplant outcome: Clinical characteristics and long-term follow-up..  108. 2024
• Developing Guidance for Donor Intervention Randomized Controlled Trials: Initial Discussions From the Canada-United Kingdom 2022 Workshop.  108:1776-1781. 2024
• Liraglutide Protects Pancreatic Islet From Ischemic Injury by Reducing Oxidative Stress and Activating Akt Signaling During Cold Preservation to Improve Islet Transplantation Outcomes.  108:e156-e169. 2024
• 213.7: A Data-driven Predictive Analytics Framework for the Analysis of Prognostic Factors and Health Outcomes in Paediatric Intestinal Failure Patients.  106:S32-S32. 2022
• 415.3: AP39 Administration During Normothermic Ex Vivo Kidney Perfusion Reduces Preservation Injury.  106:S428-S428. 2022
• Current State of Evidence on Kidney Transplantation: How Fragile Are the Results?.  106:248-256. 2022
• Antemortem Heparin in Organ Donation After Circulatory Death Determination: A Systematic Review of the Literature.  105:e337-e346. 2021
• Predicting Kidney Function 1 Year After Nephrectomy in Living Kidney Donor Candidates.  105:2350-2351. 2021
• Reporting and Handling of Missing Participant Data in Systematic Reviews of Kidney Transplant Studies.  105:1708-1717. 2021
• Living Kidney Donors’ Financial Expenses and Mental Health.  105:1356-1364. 2021
• Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy..  104:2575-2581. 2020
• A Propensity Score–weighted Comparison of Outcomes Between Living and Standard Criteria Deceased Donor Kidney Transplant Recipients.  104:e317-e327. 2020
• Incidence and Risk Factors of Obesity in Childhood Solid-Organ Transplant Recipients.  104:1644-1653. 2020
• Incidence and Risk Factors of Obesity in Childhood Solid-Organ Transplant Recipients..  104:1644-1653. 2020
• Handling of Missing Data.  104:24-26. 2020
• P4.01: Reduction of central line associated bloodstream infections and line occlusions in pediatric intestinal failure patients on long-term parenteral nutrition using an alternate locking solution, Kitelock.  103:S141-S141. 2019
• Nonreimbursed Costs Incurred by Living Kidney Donors: A Case Study From Ontario, Canada.  103:e164-e171. 2019
• Nonreimbursed Costs Incurred by Living Kidney Donors: A Case Study From Ontario, Canada..  103:e164-e171. 2019
• Socioeconomic Status and Kidney Transplant Outcomes in a Universal Healthcare System: A Population-based Cohort Study.  103:1024-1035. 2019
• Elevated Risk of Cancer After Solid Organ Transplant in Childhood: A Population-based Cohort Study.  103:588-596. 2019
• Primary Graft Dysfunction: The Devil Is in the Details..  103:229-230. 2019
• Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.  102:1367-1374. 2018
• Initiating Maintenance Dialysis Before Living Kidney Donor Transplantation When a Donor Candidate Evaluation Is Well Underway.  102:e345-e353. 2018
• Trends in Early Hospital Readmission After Kidney Transplantation, 2002 to 2014.  102:e171-e179. 2018
• Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice.  101:1801-1810. 2017
• KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.  101:S7-S105. 2017
• Summary of Kidney Disease.  101:1783-1792. 2017
• Diabetes Mellitus in Living Pancreas Donors.  101:1276-1281. 2017
• Corticosteroid Use and Growth After Pediatric Solid Organ Transplantation.  101:694-703. 2017
• The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients.  101:588-596. 2017
• Risk of Nephrectomy in Previous Living Kidney Donors.  100:1313-1317. 2016
• Early Hospital Readmissions After Transplantation.  100:713-718. 2016
• Fracture Incidence in Adult Kidney Transplant Recipients.  100:167-175. 2016
• Kidney Paired Donation Protocol for Participating Donors 2014.  99:S1-S88. 2015
• Race, Relationship and Renal Diagnoses After Living Kidney Donation.  99:1723-1729. 2015
• Time-to-Referral, Use, and Efficacy of Cardiac Rehabilitation After Heart Transplantation.  99:594-601. 2015
• Long-Term Changes in Bone Mineral Density in Kidney Transplant Recipients.  98:1279-1285. 2014
• FRAX Predicts Fracture Risk in Kidney Transplant Recipients.  97:940-945. 2014
• Consistency of Racial Variation in Medical Outcomes Among Publicly and Privately Insured Living Kidney Donors.  97:316-324. 2014
• Fracture Risk in Kidney Transplant Recipients.  95:1461-1470. 2013
• Cancer Diagnoses After Living Kidney Donation.  94:139-144. 2012
• Depression Diagnoses After Living Kidney Donation.  94:77-83. 2012
• Kidney Transplantation Search Filters for PubMed, Ovid Medline, and Embase.  93:460-466. 2012
• Increased Serum Vitamin A and E Levels After Lung Transplantation.  92:601-606. 2011
• T Lymphocyte Responses to Nonpolymorphic HLA-Derived Peptides Are Associated With Chronic Renal Allograft Dysfunction.  91:279-286. 2011
• Chronic Graft Versus Host Disease Is Associated With an Immune Response to Autologous Human Leukocyte Antigen–Derived Peptides.  90:555-563. 2010
• ENDOPLASMIC RETICULUM STRESS CONTRIBUTES TO GRAFT FAILURE IN ISLET CELL TRANSPLANTATION.  90:1005-1005. 2010
• Case Report: Drug Interaction Between Tacrolimus and Amiodarone With QT Prolongation.  89:1166-1167. 2010
• Discovering Misattributed Paternity in Living Kidney Donation: Prevalence, Preference, and Practice.  87:1429-1435. 2009
• Identification of an Expressed Truncated Form of CD200, CD200tr, which is a Physiologic Antagonist of CD200-Induced Suppression.  86:1116-1124. 2008
• Cardiovascular Disease and Hypertension Risk in Living Kidney Donors: An Analysis of Health Administrative Data in Ontario, Canada.  86:399-406. 2008
• COMPARISON OF THE EFFICACY OF AVAILABLE COLLAGENASES ON HUMAN ISLET ISOLATION FROM RESEARCH GRADE PANCREATA.  86:571-572. 2008
• REAL-TIME COMPREHENSIVE HUMAN ISLET ASSESSMENT IN VITRO USING FLUORESCENCE IMAGING AND MICROFLUIDIC PERIFUSION SYSTEM.  86:269-269. 2008
• THE MITOCHONDRIAL K-ATP CHANNEL OPENER, DIAZOXIDE, IMPROVES ISLET ISOLATION OUTCOME IN MICE COLD ISCHEMIA MODEL.  86:566-566. 2008
• Generation and Expansion of Human CD4+CD25+ Regulatory T Cells with Indirect Allospecificity: Potential Reagents to Promote Donor-Specific Transplantation Tolerance.  82:1738-1743. 2006
• Need for a Registry of Living Kidney Donor Outcomes.  82:1383-1383. 2006
• Suppressed Splenocyte Proliferation Following a Xenogeneic Skin Graft due to Implanted Biomaterials.  82:415-421. 2006
• ANALYSIS OF PREOPERATIVE RADIOLOGIC STAGING (PRS) OF HEPATOCELLULAR CARCINOMA (HCC) AND EXPLANT HISTOLOGY IN PATIENTS UNDERGOING LIVER TRANSPLANTATION (LT) AND IMPACT ON SURVIVAL..  82:873-873. 2006
• EXPOSURE-EFFICACY RELATIONSHIPS OF AN EVEROLIMUS-FTY720 REGIMEN IN KIDNEY TRANSPLANT PATIENTS AT INCREASED RISK FOR DELAYED GRAFT FUNCTION..  82:867-868. 2006
• EXPRESSION SEQUENCE TAGS RESEARCH OF A CDNA LIBRARY FROM LIVER TISSUE OF BANNA MINIPIG INBRED LINE..  82:1054-1055. 2006
• In Vivo Recognition by the Host Adaptive Immune System of Microencapsulated Xenogeneic Cells.  78:1454-1462. 2004
• Increased expression of nitric oxide synthase in human lung transplants after nitric oxide inhalation1.  77:886-890. 2004
• SIMULTANEOUS ISLET LIVER ALLOTRANSPLANTATION IN RATS.  73:320-321. 2002
• TREATMENT OF ESTABLISHED BONE LOSS AFTER RENAL TRANSPLANTATION WITH ETIDRONATE1.  71:669-673. 2001
• IS ROUTINE URETERIC STENTING NEEDED IN KIDNEY TRANSPLANTATION? A RANDOMIZED TRIAL.  70:597-601. 2000
• PLANT ALKALOID TETRANDRINE AND ITS ANALOG BLOCK CD28-COSTIMULATED ACTIVITIES OF HUMAN PERIPHERAL BLOOD T CELLS.  68:1383-1392. 1999
• IMPROVED PATIENT AND RENAL ALLOGRAFT SURVIVAL IN DIABETES MELLITUS: A SINGLE CENTER EXPERIENCE.  67:S148-S148. 1999
• PHENOTYPE, FUNCTION, AND IN VIVO MIGRATION AND SURVIVAL OF ALLOGENEIC DENDRITIC CELL PROGENITORS GENETICALLY ENGINEERED TO EXPRESS TGF-??1,2.  66:1810-1817. 1998
• TRANSPLANTED HEPATOCYTES INFECTED WITH A COMPLEMENT RECEPTOR TYPE 1 (CR1)-CONTAINING RECOMBINANT ADENOVIRUS ARE RESISTANT TO HYPERACUTE REJECTION.  66:S9-S9. 1998
• ENHANCEMENT OF DENDRITIC CELL TOLEROGENICITY BY GENETIC MODIFICATION USING ADENOVIRAL VECTORS ENCODING cDNA FOR TGF??1.  65:S22-S22. 1998
• ESTIMATING QUALITY OF LIFE IN UREMIC IDDM PATIENTS FOR THE PURPOSE OF MEDICAL DECISION ANALYSIS.  65:S94-S94. 1998
• ENHANCEMENT OF DENDRITIC CELL TOLEROGENICITY BY GENETIC MODIFICATION USING ADENOVIRAL VECTORS ENCODING cDNA FOR TGFβ1.  65:98-98. 1998
• ESTIMATING QUALITY OF LIFE IN UREMIC IDDM PATIENTS FOR THE PURPOSE OF MEDICAL DECISION ANALYSIS.  65:170-170. 1998
• IDENTIFICATION OF DONOR-DERIVED DENDRITIC CELL PROGENITORS IN BONE MARROW OF SPONTANEOUSLY TOLERANT LIVER ALLOGRAFT RECIPIENTS1,2.  60:1555-1559. 1995
• FIBRIN CLOT LYSIS BY TISSUE PLASMINOGEN ACTIVATOR (tPA) IS IMPAIRED IN PLASMA FROM PEDIATRIC PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION.  60:144-146. 1995
• ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTING.  57:1502-1507. 1994
• ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTING.  57:1502-1507. 1994
• RIGHT PHRENIC NERVE INJURY IN ORTHOTOPIC LIVER TRANSPLANTATION.  55:826-829. 1993
• THE QUALITY OF LIFE IN RENAL TRANSPLANTATION—A PROSPECTIVE STUDY.  54:656-660. 1992
• GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR FOR THE THERAPY OF CYTOMEGALOVIRUS AND GANCICLOVIR-INDUCED LEUKOPENIA IN A RENAL TRANSPLANT RECIPIENT.  53:930-931. 1992
• The relationship between cadaver donor interleukin 6 levels and delayed graft function in kidney transplantation..  53:222-223. 1992
• SURVIVAL OF GANCICLOVIR-TREATED HEART TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS PNEUMONITIS.  52:910-912. 1991
• EARLY FUNCTION AS THE PRINCIPAL CORRELATE OF GRAFT SURVIVAL.  46:223-228. 1988
• INDUCTION OF ANTIIDIOTYPIC ANTIBODIES BY BLOOD TRANSFUSIONS.  42:632-635. 1986
• RECRUITMENT OF CYTOTOXIC CELLS BY ECTOPIC GRAFTS OF XENOGENEIC, BUT NOT ALLOGENEIC, TROPHOBLAST.  37:84-90. 1984
• THE SIGNIFICANCE OF MONOCYTES IN GLOMERULI OF HUMAN RENAL TRANSPLANTS.  37:70-72. 1984
• NONSPECIFIC SUPPRESSION OF IN VITRO GENERATION OF CYTOTOXIC LYMPHOCYTES BY ALLOGENEIC AND XENOGENEIC EMBRYONIC TISSUES.  35:627-628. 1983

has subject area

• 11 Medical and Health Sciences (FoR)
• Surgery (Science Metrix)

Identity

International Standard Serial Number (ISSN)

• 0041-1337
• 1600-6135

Electronic International Standard Serial Number (EISSN)

• 1534-6080
• 1600-6143